{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:19:45Z","timestamp":1794737985439,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chimeric antigen receptor (CAR) T cell therapy is one of the most promising cancer treatments. However, different hurdles are limiting its application and efficacy. In this context, how aging influences CAR-T cell outcomes is largely unknown. Here we show that CAR-T cells generated from aged female mice present a mitochondrial dysfunction derived from nicotinamide adenine dinucleotide (NAD) depletion that leads to poor stem-like properties and limited functionality in vivo. Moreover, human data analysis revealed that both age and NAD metabolism determine the responsiveness to CAR-T cell therapy. Targeting NAD pathways, we were able to recover the mitochondrial fitness and functionality of CAR-T cells derived from older adults. Altogether, our study demonstrates that aging is a limiting factor to successful CAR-T cell responses. Repairing metabolic and functional obstacles derived from age, such as NAD decline, is a promising strategy to improve current and future CAR-T cell therapies.<\/jats:p>","DOI":"10.1038\/s43018-025-00982-7","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T06:14:44Z","timestamp":1747721684000},"page":"1524-1536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5583-4510","authenticated-orcid":false,"given":"Helen Carrasco","family":"Hope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"de Sostoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3254-1269","authenticated-orcid":false,"given":"Pierpaolo","family":"Ginefra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8036-2647","authenticated-orcid":false,"given":"Massimo","family":"Andreatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsuan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ronet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-749X","authenticated-orcid":false,"given":"Christine","family":"Pich-Bavastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6844-6170","authenticated-orcid":false,"given":"Jes\u00fas","family":"Corria Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6137-7483","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Kuonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Auwerx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"D\u2019Amelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-3774","authenticated-orcid":false,"given":"Ping-Chih","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-0671","authenticated-orcid":false,"given":"Santiago J.","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8813-7367","authenticated-orcid":false,"given":"George","family":"Coukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0151-3222","authenticated-orcid":false,"given":"Denis","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-7512","authenticated-orcid":false,"given":"Nicola","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"982_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.780442","volume":"12","author":"PH Mehta","year":"2021","unstructured":"Mehta, P. H. et al. T cell fitness and autologous CAR T cell therapy in haematologic malignancy. Front. Immunol. 12, 780442 (2021).","journal-title":"Front. Immunol."},{"key":"982_CR2","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3389\/fonc.2019.01237","volume":"9","author":"J Cheng","year":"2019","unstructured":"Cheng, J. et al. Understanding the mechanisms of resistance to CAR T-cell therapy in malignancies. Front. Oncol. 9, 1237 (2019).","journal-title":"Front. Oncol."},{"key":"982_CR3","first-page":"372","volume":"16","author":"NN Shah","year":"2019","unstructured":"Shah, N. N. & Fry, T. J. Mechanisms of resistance to CAR T cell therapy. Nat. Rev. Clin. Oncol. 16, 372\u2013385 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"982_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103\u2013107 (2009).","journal-title":"Nature"},{"key":"982_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJW van der Windt","year":"2012","unstructured":"van der Windt, G. J. W. et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68\u201378 (2012).","journal-title":"Immunity"},{"key":"982_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-065X.2012.01150.x","volume":"249","author":"GJW van der Windt","year":"2012","unstructured":"van der Windt, G. J. W. & Pearce, E. L. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 249, 27\u201342 (2012).","journal-title":"Immunol. Rev."},{"key":"982_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cell.2017.08.018","volume":"171","author":"RI Klein Geltink","year":"2017","unstructured":"Klein Geltink, R. I. et al. Mitochondrial Priming by CD28. Cell 171, 385\u2013397 (2017).","journal-title":"Cell"},{"key":"982_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41577-021-00539-6","volume":"21","author":"JD Chan","year":"2021","unstructured":"Chan, J. D. et al. Cellular networks controlling T cell persistence in adoptive cell therapy. Nat. Rev. Immunol. 21, 769\u2013784 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"982_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1182\/blood.2018885863","volume":"134","author":"JAC van Bruggen","year":"2019","unstructured":"van Bruggen, J. A. C. et al. Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy. Blood 134, 44\u201358 (2019).","journal-title":"Blood"},{"key":"982_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41591-021-01248-2","volume":"27","author":"JA Fraietta","year":"2021","unstructured":"Fraietta, J. A. et al. Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat. Med. 27, 561 (2021).","journal-title":"Nat. Med."},{"key":"982_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2020.12.004","volume":"500","author":"H Rostamian","year":"2021","unstructured":"Rostamian, H. et al. A metabolic switch to memory CAR T cells: implications for cancer treatment. Cancer Lett. 500, 107\u2013118 (2021).","journal-title":"Cancer Lett."},{"key":"982_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","volume":"7","author":"D Alizadeh","year":"2019","unstructured":"Alizadeh, D. et al. IL15 enhances CAR T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype. Cancer Immunol. Res. 7, 759\u2013772 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"982_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cmet.2022.03.013","volume":"34","author":"M Wenes","year":"2022","unstructured":"Wenes, M. et al. The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function. Cell Metab. 34, 731\u2013746 (2022).","journal-title":"Cell Metab."},{"key":"982_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41586-023-06546-y","volume":"621","author":"A Jaccard","year":"2023","unstructured":"Jaccard, A. et al. Reductive carboxylation epigenetically instructs T cell differentiation. Nature 621, 849\u2013856 (2023).","journal-title":"Nature"},{"key":"982_CR15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.immuni.2016.02.023","volume":"44","author":"OU Kawalekar","year":"2016","unstructured":"Kawalekar, O. U. et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity 44, 712 (2016).","journal-title":"Immunity"},{"key":"982_CR16","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","volume":"18","author":"N Dumauthioz","year":"2021","unstructured":"Dumauthioz, N. et al. Enforced PGC-1\u03b1 expression promotes CD8 T cell fitness, memory formation and antitumor immunity. Cell. Mol. Immunol. 18, 1761\u20131771 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"982_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","volume":"2","author":"E Katsyuba","year":"2020","unstructured":"Katsyuba, E., Romani, M., Hofer, D. & Auwerx, J. NAD+ homeostasis in health and disease. Nat Metab. 2, 9\u201331 (2020).","journal-title":"Nat Metab."},{"key":"982_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","volume":"22","author":"C Cant\u00f3","year":"2015","unstructured":"Cant\u00f3, C., Menzies, K. J. & Auwerx, J. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22, 31\u201353 (2015).","journal-title":"Cell Metab."},{"key":"982_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6101","volume":"5","author":"SG Tullius","year":"2014","unstructured":"Tullius, S. G. et al. NAD+ protects against EAE by regulating CD4+ T-cell differentiation. Nat. Commun. 5, 5101 (2014).","journal-title":"Nat. Commun."},{"key":"982_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109516","volume":"36","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells. Cell Rep. 36, 109516 (2021).","journal-title":"Cell Rep."},{"key":"982_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cmet.2017.10.006","volume":"27","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee, S. et al. CD38\u2013NAD+ axis regulates immunotherapeutic anti-tumor T cell response. Cell Metab. 27, 85\u2013100 (2018).","journal-title":"Cell Metab."},{"key":"982_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113518","volume":"42","author":"J Wan","year":"2023","unstructured":"Wan, J. et al. De novo NAD+ synthesis contributes to CD8+ T cell metabolic fitness and antitumor function. Cell Rep. 42, 113518 (2023).","journal-title":"Cell Rep."},{"key":"982_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu, Y. R. et al. Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion. Nat. Immunol. 21, 1540\u20131551 (2020).","journal-title":"Nat. Immunol."},{"key":"982_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101840","volume":"70","author":"JH Noll","year":"2023","unstructured":"Noll, J. H., Levine, B. L., June, C. H. & Fraietta, J. A. Beyond youth: understanding CAR T cell fitness in the context of immunological aging. Semin. Immunol. 70, 101840 (2023).","journal-title":"Semin. Immunol."},{"key":"982_CR25","doi-asserted-by":"publisher","first-page":"e62420","DOI":"10.7554\/eLife.62420","volume":"9","author":"JM Drijvers","year":"2020","unstructured":"Drijvers, J. M., Sharpe, A. H. & Haigis, M. C.The effects of age and systemic metabolism on anti-tumor T cell responses. eLife 9, e62420 (2020).","journal-title":"eLife"},{"key":"982_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"982_CR27","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","volume":"23","author":"J Camacho-Pereira","year":"2016","unstructured":"Camacho-Pereira, J. et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 23, 1127\u20131139 (2016).","journal-title":"Cell Metab."},{"key":"982_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias, A. J., Perrone, R., Grozio, A. & Verdin, E. NAD+ metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 22, 119\u2013141 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"982_CR29","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","volume":"154","author":"L Mouchiroud","year":"2013","unstructured":"Mouchiroud, L. et al. The NAD+\/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154, 430\u2013441 (2013).","journal-title":"Cell"},{"key":"982_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40425-018-0385-z","volume":"6","author":"BO Tschumi","year":"2018","unstructured":"Tschumi, B. O. et al. CART cells are prone to Fas- and DR5-mediated cell death. J. Immunother. Cancer 6, 71 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"982_CR31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.immuni.2020.09.005","volume":"53","author":"D Pais Ferreira","year":"2020","unstructured":"Pais Ferreira, D. et al. Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation. Immunity 53, 985\u20131000 (2020).","journal-title":"Immunity"},{"key":"982_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211 (2019).","journal-title":"Immunity"},{"key":"982_CR33","doi-asserted-by":"publisher","first-page":"109672","DOI":"10.1016\/j.celrep.2021.109672","volume":"36","author":"M Charmoy","year":"2021","unstructured":"Charmoy, M., Wyss, T., Delorenzi, M. & Held, W. PD-1+ Tcf1+ CD8+ T cells from established chronic infection can form memory while retaining a stable imprint of persistent antigen exposure. Cell Rep. 36, 109672 (2021).","journal-title":"Cell Rep."},{"key":"982_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2018.07.018","volume":"49","author":"D O\u2019Sullivan","year":"2018","unstructured":"O\u2019Sullivan, D. et al. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 49, 375\u2013376 (2018).","journal-title":"Immunity"},{"key":"982_CR35","doi-asserted-by":"publisher","first-page":"e148546","DOI":"10.1172\/JCI148546","volume":"132","author":"M Corrado","year":"2022","unstructured":"Corrado, M. & Pearce, E. L.Targeting memory T cell metabolism to improve immunity. J. Clin. Invest. 132, e148546 (2022).","journal-title":"J. Clin. Invest."},{"key":"982_CR36","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desd\u00edn-Mic\u00f3","year":"2020","unstructured":"Desd\u00edn-Mic\u00f3, G. et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368, 1371 (2020).","journal-title":"Science"},{"key":"982_CR37","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","volume":"21","author":"SA Vardhana","year":"2020","unstructured":"Vardhana, S. A. et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat. Immunol. 21, 1022\u20131033 (2020).","journal-title":"Nat. Immunol."},{"key":"982_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping, N. E. et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat. Immunol. 22, 205\u2013215 (2021).","journal-title":"Nat. Immunol."},{"key":"982_CR39","doi-asserted-by":"publisher","first-page":"e01091","DOI":"10.1002\/cti2.1091","volume":"8","author":"KM Quinn","year":"2019","unstructured":"Quinn, K. M., Palchaudhuri, R., Palmer, C. S. & La Gruta, N. L. The clock is ticking: the impact of ageing on T cell metabolism. Clin. Transl. Immunol. 8, e01091 (2019).","journal-title":"Clin. Transl. Immunol."},{"key":"982_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16633-7","volume":"11","author":"KM Quinn","year":"2020","unstructured":"Quinn, K. M. et al. Metabolic characteristics of CD8+ T cell subsets in young and aged individuals are not predictive of functionality. Nat. Commun. 11, 2857 (2020).","journal-title":"Nat. Commun."},{"key":"982_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13299","volume":"20","author":"Y Nian","year":"2021","unstructured":"Nian, Y. et al. Targeting age-specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survival. Aging Cell 20, e13299 (2021).","journal-title":"Aging Cell"},{"key":"982_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.stem.2019.02.012","volume":"24","author":"N Vannini","year":"2019","unstructured":"Vannini, N. et al. The NAD-booster nicotinamide riboside potently stimulates hematopoiesis through increased mitochondrial clearance. Cell Stem Cell 24, 405\u2013418 (2019).","journal-title":"Cell Stem Cell"},{"key":"982_CR43","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/cells9071716","volume":"9","author":"A Kar","year":"2020","unstructured":"Kar, A., Mehrotra, S. & Chatterjee, S.CD38: T cell immuno-metabolic modulator. Cells 9, 1716 (2020).","journal-title":"Cells"},{"key":"982_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113395","volume":"153","author":"W Li","year":"2022","unstructured":"Li, W., Liang, L., Liao, Q., Li, Y. & Zhou, Y. CD38: an important regulator of T cell function. Biomed. Pharmacother. 153, 113395 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"982_CR45","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s42255-020-00298-z","volume":"2","author":"CCS Chini","year":"2020","unstructured":"Chini, C. C. S. et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. Nat. Metab. 2, 1284\u20131304 (2020).","journal-title":"Nat. Metab."},{"key":"982_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.014","volume":"38","author":"S Hurtado-Bag\u00e8s","year":"2020","unstructured":"Hurtado-Bag\u00e8s, S., Knobloch, G., Ladurner, A. G. & Buschbeck, M. The taming of PARP1 and its impact on NAD+ metabolism. Mol. Metab. 38, 100950 (2020).","journal-title":"Mol. Metab."},{"key":"982_CR47","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cmet.2018.03.016","volume":"27","author":"MG Tarrago","year":"2018","unstructured":"Tarrago, M. G. et al. A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline. Cell Metab. 27, 1081\u20131095 (2018).","journal-title":"Cell Metab."},{"key":"982_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cell.2020.08.022","volume":"183","author":"KR Parker","year":"2020","unstructured":"Parker, K. R. et al. Single-cell analyses identify brain mural cells expressing CD19 as potential off-tumor targets for CAR-T immunotherapies. Cell 183, 126\u2013142 (2020).","journal-title":"Cell"},{"key":"982_CR49","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/s41591-022-01959-0","volume":"28","author":"NJ Haradhvala","year":"2022","unstructured":"Haradhvala, N. J. et al. Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma. Nat. Med. 28, 1848\u20131859 (2022).","journal-title":"Nat. Med."},{"key":"982_CR50","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1158\/2159-8290.CD-20-1677","volume":"11","author":"GM Chen","year":"2021","unstructured":"Chen, G. M. et al. Integrative bulk and single-cell profiling of premanufacture T-cell populations reveals factors mediating long-term persistence of CAR T-cell therapy. Cancer Discov. 11, 2186\u20132199 (2021).","journal-title":"Cancer Discov."},{"key":"982_CR51","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998\u20131013 (2018).","journal-title":"Cell"},{"key":"982_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cmet.2022.11.001","volume":"35","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L. & Kroemer, G. Meta-hallmarks of aging and cancer. Cell Metab. 35, 12\u201335 (2023).","journal-title":"Cell Metab."},{"key":"982_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2022.11.005","volume":"35","author":"S Han","year":"2023","unstructured":"Han, S., Georgiev, P., Ringel, A. E., Sharpe, A. H. & Haigis, M. C. Age-associated remodeling of T cell immunity and metabolism. Cell Metab. 35, 36\u201355 (2023).","journal-title":"Cell Metab."},{"key":"982_CR54","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.exger.2017.12.025","volume":"105","author":"\u00c1 Padr\u00f3n","year":"2018","unstructured":"Padr\u00f3n, \u00c1. et al. Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model. Exp. Gerontol. 105, 146\u2013154 (2018).","journal-title":"Exp. Gerontol."},{"key":"982_CR55","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1158\/0008-5472.CAN-11-3019","volume":"72","author":"V Hurez","year":"2012","unstructured":"Hurez, V. et al. Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice. Cancer Res. 72, 2089\u20132099 (2012).","journal-title":"Cancer Res."},{"key":"982_CR56","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1158\/1078-0432.CCR-18-1116","volume":"24","author":"CH Kugel","year":"2018","unstructured":"Kugel, C. H. et al. Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-cell populations. Clin. Cancer Res. 24, 5347\u20135356 (2018).","journal-title":"Clin. Cancer Res."},{"key":"982_CR57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/aac2.12045","volume":"3","author":"MG Garcia","year":"2022","unstructured":"Garcia, M. G. et al. Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice. Aging Cancer 3, 68\u201383 (2022).","journal-title":"Aging Cancer"},{"key":"982_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101400","volume":"5","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism. Cell Rep. Med. 5, 101400 (2024).","journal-title":"Cell Rep. Med."},{"key":"982_CR59","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41590-019-0336-y","volume":"20","author":"AM Cameron","year":"2019","unstructured":"Cameron, A. M. et al. Inflammatory macrophage dependence on NAD+ salvage is a consequence of reactive oxygen species-mediated DNA damage. Nat. Immunol. 20, 420\u2013432 (2019).","journal-title":"Nat. Immunol."},{"key":"982_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-018-0255-3","volume":"20","author":"PS Minhas","year":"2019","unstructured":"Minhas, P. S. et al. Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation. Nat. Immunol. 20, 50\u201363 (2019).","journal-title":"Nat. Immunol."},{"key":"982_CR61","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1158\/2767-9764.CRC-24-0022","volume":"4","author":"P Ginefra","year":"2024","unstructured":"Ginefra, P. et al. Urolithin-A promotes CD8+ T cell-mediated cancer immunosurveillance via FOXO1 activation. Cancer Res. Commun. 4, 1189\u20131198 (2024).","journal-title":"Cancer Res. Commun."},{"key":"982_CR62","doi-asserted-by":"publisher","first-page":"1027856","DOI":"10.3389\/fendo.2022.1027856","volume":"13","author":"A M\u00fchlethaler-Mottet","year":"2022","unstructured":"M\u00fchlethaler-Mottet, A. et al. Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension. Front. Endocrinol. 13, 1027856 (2022).","journal-title":"Front. Endocrinol."},{"key":"982_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"982_CR64","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1093\/bioinformatics\/btac141","volume":"38","author":"M Andreatta","year":"2022","unstructured":"Andreatta, M., Berenstein, A. J. & Carmona, S. J. scGate: marker-based purification of cell types from heterogeneous single-cell RNA-seq datasets. Bioinformatics 38, 2642\u20132644 (2022).","journal-title":"Bioinformatics"},{"key":"982_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).","journal-title":"Nat. Commun."},{"key":"982_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45240-z","volume":"15","author":"M Andreatta","year":"2024","unstructured":"Andreatta, M. et al. Semi-supervised integration of single-cell transcriptomics data. Nat. Commun. 15, 872 (2024).","journal-title":"Nat. Commun."},{"key":"982_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database Hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"982_CR68","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput. Struct. Biotechnol. J. 19, 3796\u20133798 (2021).","journal-title":"Comput. Struct. Biotechnol. J."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00982-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:03:00Z","timestamp":1769443380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00982-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1038\/s43018-025-00982-7","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, the text \u201cN.V. and D.M. were supported by the Ligue Genevoise contre le Cancer (LGC-2308)\u201d was missing from the Acknowledgements section and has now been added to the HTML and PDF versions of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Some elements of this work are part of PCT application no. PCT\/EP2024\/080878, titled \u2018Method for suppressing CAR-T cells unresponsiveness for improving cancer immunotherapy\u2019, for which H.C.H., P.G. and N.V. are listed as inventors. J.A. is an advisor to MetroBiotech International and Mitopower, who develop strategies to enhance NAD levels. D.M. is an inventor on patents related to CAR-T cell therapy, filed by the University of Pennsylvania and the University of Geneva, is the scientific cofounder of Cellula Therapeutics and is a consultant for Carthera, Servier Pharma, Limula and MPC Therapeutics. N.V. is a scientific advisor of Clinique La Prairie. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}